A cannabinoid mechanism in relapse to cocaine seeking - PubMed

A cannabinoid mechanism in relapse to cocaine seeking

T J De Vries et al. Nat Med. 2001 Oct.

Abstract

Treatment of cocaine addiction is hampered by high rates of relapse even after prolonged drug abstinence. This relapse to compulsive cocaine use can be triggered by re-exposure to cocaine, by re-exposure to stimuli previously associated with cocaine or by exposure to stress. In laboratory rats, similar events reinstate cocaine seeking after prolonged withdrawal periods, thus providing a model to study neuronal mechanisms underlying the relapse to cocaine. The endocannabinoid system has been implicated in a number of neuropsychiatric conditions, including drug addiction. The active ingredient of marijuana, Delta9-tetrahydrocannabinol, activates the mesolimbic dopamine (DA) reward system and has rewarding effects in preclinical models of drug abuse. We report here that the synthetic cannabinoid agonist, HU210 (ref. 13), provokes relapse to cocaine seeking after prolonged withdrawal periods. Furthermore, the selective CB1 receptor antagonist, SR141716A (ref. 14), attenuates relapse induced by re-exposure to cocaine-associated cues or cocaine itself, but not relapse induced by exposure to stress. These data reveal an important role of the cannabinoid system in the neuronal processes underlying relapse to cocaine seeking, and provide a rationale for the use of cannabinoid receptor antagonists for the prevention of relapse to cocaine use.

Comment in

• Cannabinoid activity curtails cocaine craving.

  Piomelli D. Piomelli D. Nat Med. 2001 Oct;7(10):1099-100. doi: 10.1038/nm1001-1099. Nat Med. 2001. PMID: 11590424 No abstract available.

Similar articles

• Cannabinoid activity curtails cocaine craving.

  Piomelli D. Piomelli D. Nat Med. 2001 Oct;7(10):1099-100. doi: 10.1038/nm1001-1099. Nat Med. 2001. PMID: 11590424 No abstract available.

• Cannabinoid receptors and reward in the rat: a conditioned place preference study.

  Cheer JF, Kendall DA, Marsden CA. Cheer JF, et al. Psychopharmacology (Berl). 2000 Jul;151(1):25-30. doi: 10.1007/s002130000481. Psychopharmacology (Berl). 2000. PMID: 10958113

• CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.

  Spano MS, Fattore L, Cossu G, Deiana S, Fadda P, Fratta W. Spano MS, et al. Br J Pharmacol. 2004 Oct;143(3):343-50. doi: 10.1038/sj.bjp.0705932. Epub 2004 Aug 31. Br J Pharmacol. 2004. PMID: 15339858 Free PMC article.

• The role of CB1 receptors in psychostimulant addiction.

  Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ. Wiskerke J, et al. Addict Biol. 2008 Jun;13(2):225-38. doi: 10.1111/j.1369-1600.2008.00109.x. Addict Biol. 2008. PMID: 18482432 Review.

• An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

  Fattore L, Spano MS, Deiana S, Melis V, Cossu G, Fadda P, Fratta W. Fattore L, et al. Brain Res Rev. 2007 Jan;53(1):1-16. doi: 10.1016/j.brainresrev.2006.05.003. Epub 2006 Jul 12. Brain Res Rev. 2007. PMID: 16839608 Review.

Cited by

• Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.

  Soler-Cedeno O, Xi ZX. Soler-Cedeno O, et al. Cells. 2022 Oct 17;11(20):3262. doi: 10.3390/cells11203262. Cells. 2022. PMID: 36291128 Free PMC article. Review.

• The reinstatement model of drug relapse: history, methodology and major findings.

  Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. Shaham Y, et al. Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20. doi: 10.1007/s00213-002-1224-x. Epub 2002 Oct 26. Psychopharmacology (Berl). 2003. PMID: 12402102 Review.

• The cannabinoid receptor-1 gene interacts with stressful life events to increase the risk for problematic alcohol use.

  Bornscheuer L, Lundin A, Forsell Y, Lavebratt C, Melas PA. Bornscheuer L, et al. Sci Rep. 2022 Mar 23;12(1):4963. doi: 10.1038/s41598-022-08980-w. Sci Rep. 2022. PMID: 35322131 Free PMC article.

• FAAH selectively influences placebo effects.

  Peciña M, Martínez-Jauand M, Hodgkinson C, Stohler CS, Goldman D, Zubieta JK. Peciña M, et al. Mol Psychiatry. 2014 Mar;19(3):385-91. doi: 10.1038/mp.2013.124. Epub 2013 Sep 17. Mol Psychiatry. 2014. PMID: 24042479 Free PMC article. Clinical Trial.

• The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

  Hutchison KE, Haughey H, Niculescu M, Schacht J, Kaiser A, Stitzel J, Horton WJ, Filbey F. Hutchison KE, et al. Arch Gen Psychiatry. 2008 Jul;65(7):841-50. doi: 10.1001/archpsyc.65.7.841. Arch Gen Psychiatry. 2008. PMID: 18606956 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Medical

  • MedlinePlus Health Information